1921
Volume 99, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

is a rare, potentially serious pathogen. Most clinicians have no experience with its clinical appearance or treatment. We describe a case of a child presenting with necrotizing pneumonia caused by . We describe case complexities, including the need for a multidisciplinary approach to diagnosis and treatment.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.18-0060
2018-04-23
2019-11-18
Loading full text...

Full text loading...

/deliver/fulltext/14761645/99/1/tpmd180060.html?itemId=/content/journals/10.4269/ajtmh.18-0060&mimeType=html&fmt=ahah

References

  1. Nicolaou EV, Bartlett AH, , 2017. Necrotizing pneumonia. Pediatr Ann 46: e65e68. [Google Scholar]
  2. Chiriaco M, Salfa I, Di Matteo G, Rossi P, Finocchi A, , 2016. Chronic granulomatous disease: clinical, molecular, and therapeutic aspects. Pediatr Allergy Immunol 27: 242253. [Google Scholar]
  3. Diez Perez JA, Garcia J, Rodriguez Villamizar LA, , 2007. Sepsis by Chromobacterium violaceum: first case report from Columbia. Braz J Infect Dis 11: 441442. [Google Scholar]
  4. Sneath PH, Whelan JP, Singh RB, Edwards D, , 1953. Fatal infection by Chromobacterium violaceum. Lancet 262: 276277. [Google Scholar]
  5. Brazilian National Genome Project Consortium, 2003. The complete genome sequence of Chromobacterium violaceum reveals remarkable and exploitable bacterial adaptability. Proc Natl Acad Sci USA 100: 1166011665. [Google Scholar]
  6. Koburger JA, May SO, , 1982. Isolation of Chromobacterium spp. from foods, soil, and water. Appl Environ Microbiol 44: 14631465. [Google Scholar]
  7. Fisher RG, , 2009. Chromobacterium violaceum. Feigin RD, Cherry J, Demmler-Harrison GJ, Kaplan SL, eds. Textbook of Pediatric Infectious Diseases, 6th edition. Philadelphia, PA: Saunders Elsevier, 1632–1634.
  8. Yang CH, Li YH, , 2011. Chromobacterium violaceum infection: a clinical review of an important but neglected infection. J Chin Med Assoc 74: 435441. [Google Scholar]
  9. Lima-Bittencourt CI, Astolfi-Filho S, Chartone-Souza E, Santos FR, Nascimento AMA, , 2007. Analysis of Chromobacterium sp. natural isolates from different Brazilian ecosystems. BMC Microbiol 7: 58. [Google Scholar]
  10. Macher AM, Casale TB, Fauci AS, , 1982. Chronic granulomatous disease of childhood and Chromobacterium violaceum infection in the southeastern United States. Ann Intern Med 97: 5155. [Google Scholar]
  11. Mamlok RJ, Mamlok V, Mills GC, Daeschner CW, Schmalstieg FC, Anderson DC, , 1987. Glucose-6-phosphate dehydrogenase deficiency, neutrophil dysfunction, and Chromobacterium violaceum sepsis. J Pediatr 111: 852854. [Google Scholar]
  12. Aldridge KE, Valainis GT, Sanders CV, , 1988. Comparison of the in vitro activity of ciprofloxacin and twenty-four other antimicrobial agents against clinical strains of Chromobacterium violaceum. Diagn Microbiol Infect Dis 10: 3139. [Google Scholar]
  13. Richard KR, Lovvorn JJ, Oliver SE, Ross SA, Benner KW, Kong MYF, , 2015. Chromobacterium violaceum sepsis: rethinking conventional therapy to improve outcome. Am J Case Rep 16: 740744. [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.18-0060
Loading
/content/journals/10.4269/ajtmh.18-0060
Loading

Data & Media loading...

  • Received : 22 Jan 2018
  • Accepted : 08 Mar 2018
  • Published online : 23 Apr 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error